Episode Details
Back to Episodes330: How a Trump presidency could affect the FDA, the biotech industry, and its stocks
Published 1 year, 11 months ago
Description
To dig into how the election results could affect all things biopharma, we brought on three guests for this episode: Lizzy Lawrence, STAT’s FDA reporter, Baird analyst Brian Skorney, and longtime biotech executive Daphne Zohar.